The effect of alpha‐lipoic acid on inflammatory markers and body composition in obese patients with non‐alcoholic fatty liver disease: A randomized, double‐blind …

S Hosseinpour‐Arjmand, F Amirkhizi… - Journal of clinical …, 2019 - Wiley Online Library
What is known and objective Non‐alcoholic fatty liver disease (NAFLD) is the most common
cause of chronic liver injury. Some animal studies suggest that alpha‐lipoic acid (ALA) can …

The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind …

S Hosseinpour-Arjmand, F Amirkhizi… - 2019 - pubmed.ncbi.nlm.nih.gov
What is known and objective Non-alcoholic fatty liver disease (NAFLD) is the most common
cause of chronic liver injury. Some animal studies suggest that alpha-lipoic acid (ALA) can …

The effect of alpha‐lipoic acid on inflammatory markers and body composition in obese patients with non‐alcoholic fatty liver disease: A randomized, double‐blind …

S Hosseinpour‐Arjmand, F Amirkhizi… - Journal of Clinical …, 2019 - search.ebscohost.com
What is known and objective: Non‐alcoholic fatty liver disease (NAFLD) is the most common
cause of chronic liver injury. Some animal studies suggest that alpha‐lipoic acid (ALA) can …

The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: a randomized, double-blind …

S Hosseinpour-Arjmand, F Amirkhizi… - 2019 - cabidigitallibrary.org
What is known and objective: Non-alcoholic fatty liver disease (NAFLD) is the most common
cause of chronic liver injury. Some animal studies suggest that alpha-lipoic acid (ALA) can …

The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind …

S Hosseinpour-Arjmand, F Amirkhizi… - Journal of Clinical …, 2018 - europepmc.org
Methods In the current randomized, double-blind, placebo-controlled clinical trial, 50 obese
patients with NAFLD were randomly allocated to either" ALA"(received 1200 mg ALA as two …

The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind …

S Hosseinpour-Arjmand, F Amirkhizi… - Journal of Clinical …, 2019 - eprints.zbmu.ac.ir
What is known and objective Non-alcoholic fatty liver disease (NAFLD) is the most common
cause of chronic liver injury. Some animal studies suggest that alpha-lipoic acid (ALA) can …

The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind …

S Hosseinpour-Arjmand, F Amirkhizi… - Journal of Clinical …, 2019 - eprints.zbmu.ac.ir
What is known and objective Non-alcoholic fatty liver disease (NAFLD) is the most common
cause of chronic liver injury. Some animal studies suggest that alpha-lipoic acid (ALA) can …